Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Completed1
Other1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT01301937Phase 2/3Unknown
Low Antimonial Dosage in American Mucosal Leishmaniasis
Mucocutaneous LeishmaniasisMucosal Leishmaniasis
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Franco M Piazza, MD, MPh

Access to Advanced Health Institute (AAHI)

Related
3 trials

Shared therapeutic areas:

Leishmaniasis, CutaneousLeishmaniasis, Mucocutaneous
Similarity Score20%

Jaime Soto, MD

Fundacion Nacional de Dermatologia

Related
4 trials

Shared therapeutic areas:

Leishmaniasis, CutaneousLeishmaniasis, Mucocutaneous
Similarity Score20%

Marcos López, PhD

The University of Akron

Related
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score10%

Paulo Machado

Federal University of Bahia

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score10%

Patricio López-Jaramillo, MD, PhD

Cardiovascular Foundation of Colombia

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score10%

Jaime Soto

Fundación Nacional de Dermatología

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score10%

Juan Miguel Pascale

Instituto Conmemorativo Gorgas de Estudios de la Salud

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score10%

Edgar M Carvalho, MD, PhD

Federal University of Bahia

Related
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous

Worked with same sponsors:

Conselho Nacional de Desenvolvimento Científico e Tecnológico
Similarity Score10%

Rick M Fairhurst, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
8 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score10%

Charles Lacey, BMBS, MD

University of York

Related
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01301924Phase 2/3StudyDirector

Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis

Cutaneous Leishmaniasis
Completed
NCT01301937Phase 2/3StudyDirector

Low Antimonial Dosage in American Mucosal Leishmaniasis

Mucocutaneous LeishmaniasisMucosal Leishmaniasis
Unknown

All 2 trials loaded